Who owns LIGAND PHARMACEUTICALS INC?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of LGND from SEC Form 13F filings across 417 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 417 institutions disclosed 22.6M shares of LIGAND PHARMACEUTICALS INC worth $7.15B — about 112.8% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
417
13F holders
$7.15B
value, 2026 filers
112.8%
of shares outstanding (22.6M sh)
104
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of LGND's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3.1M | $980.2M | 0.0% | 15.5% | +4.7% |
| 2 | Invesco Ltd. | 1.2M | $379.8M | 0.0% | 6% | +45.9% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.1M | $359.8M | 0.0% | 5.7% | +3.5% |
| 4 | Jupiter Topco LLCNEW | 1.0M | $328.9M | 0.1% | 5.2% | new |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 870,950 | $275.3M | 0.0% | 4.3% | +2.7% |
| 6 | STATE STREET CORP | 826,539 | $261.3M | 0.0% | 4.1% | +6.1% |
| 7 | FMR LLC | 762,827 | $241.1M | 0.0% | 3.8% | +28.0% |
| 8 | FRANKLIN RESOURCES INC | 752,044 | $237.7M | 0.1% | 3.7% | +31.2% |
| 9 | CONGRESS ASSET MANAGEMENT CO | 659,911 | $208.6M | 1.3% | 3.3% | +30.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 589,020 | $186.2M | 0.0% | 2.9% | +5.4% |
| 11 | NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 568,371 | $179.7M | 0.3% | 2.8% | -0.9% |
| 12 | Chicago Capital, LLC | 553,435 | $174.9M | 4.2% | 2.8% | -1.5% |
| 13 | Stephens Investment Management Group LLC | 475,609 | $150.3M | 1.6% | 2.4% | -3.9% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 429,314 | $135.7M | 0.0% | 2.1% | +1.0% |
| 15 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 375,762 | $118.8M | 0.0% | 1.9% | -8.7% |
| 16 | GOLDMAN SACHS GROUP INC | 323,245 | $102.2M | 0.0% | 1.6% | -15.2% |
| 17 | LOOMIS SAYLES & CO L P | 291,805 | $92.2M | 0.1% | 1.5% | -17.4% |
| 18 | RICE HALL JAMES & ASSOCIATES, LLC | 270,052 | $85.4M | 4.2% | 1.3% | -4.8% |
| 19 | Ranger Investment Management, L.P. | 257,596 | $81.4M | 5.2% | 1.3% | -3.9% |
| 20 | NORTHERN TRUST CORP | 257,389 | $81.4M | 0.0% | 1.3% | +1.3% |
| 21 | VICTORY CAPITAL MANAGEMENT INC | 253,764 | $80.2M | 0.0% | 1.3% | -16.3% |
| 22 | DEUTSCHE BANK AG\ | 249,611 | $78.9M | 0.0% | 1.2% | -18.5% |
| 23 | NEUBERGER BERMAN GROUP LLC | 248,355 | $78.5M | 0.1% | 1.2% | +16887.3% |
| 24 | GW&K Investment Management, LLC | 246,883 | $78.0M | 0.6% | 1.2% | +65.1% |
| 25 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 210,427 | $66.5M | 0.0% | 1% | -1.2% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.